These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37749872)

  • 1. Btg2 Promotes Focal Segmental Glomerulosclerosis via Smad3-Dependent Podocyte-Mesenchymal Transition.
    Dan Hu Q; Wang HL; Liu J; He T; Tan RZ; Zhang Q; Su HW; Kantawong F; Lan HY; Wang L
    Adv Sci (Weinh); 2023 Nov; 10(32):e2304360. PubMed ID: 37749872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baicalin alleviates adriamycin-induced focal segmental glomerulosclerosis and proteinuria by inhibiting the Notch1-Snail axis mediated podocyte EMT.
    Dou Y; Shang Y; Shen Y; Qu J; Liu C; Cao J
    Life Sci; 2020 Sep; 257():118010. PubMed ID: 32598932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergism of calycosin and bone marrow-derived mesenchymal stem cells to combat podocyte apoptosis to alleviate adriamycin-induced focal segmental glomerulosclerosis.
    Hu QD; Tan RZ; Zou YX; Li JC; Fan JM; Kantawong F; Wang L
    World J Stem Cells; 2023 Jun; 15(6):617-631. PubMed ID: 37424951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial mitochondrial oxidative stress determines podocyte depletion in segmental glomerulosclerosis.
    Daehn I; Casalena G; Zhang T; Shi S; Fenninger F; Barasch N; Yu L; D'Agati V; Schlondorff D; Kriz W; Haraldsson B; Bottinger EP
    J Clin Invest; 2014 Apr; 124(4):1608-21. PubMed ID: 24590287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose of multi-glycoside of Tripterygium wilfordii Hook. f., a natural regulator of TGF-β1/Smad signaling activity improves adriamycin-induced glomerulosclerosis in vivo.
    Wan YG; Che XY; Sun W; Huang YR; Meng XJ; Chen HL; Shi XM; Tu Y; Wu W; Liu YL
    J Ethnopharmacol; 2014 Feb; 151(3):1079-1089. PubMed ID: 24362077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the ERK1/2-mTORC1 axis ameliorates proteinuria and the fibrogenic action of transforming growth factor-β in Adriamycin-induced glomerulosclerosis.
    Das R; Kim SJ; Nguyen NT; Kwon HJ; Cha SK; Park KS
    Kidney Int; 2019 Oct; 96(4):927-941. PubMed ID: 31377057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms and consequences of TGF-ß overexpression by podocytes in progressive podocyte disease.
    Lee HS
    Cell Tissue Res; 2012 Jan; 347(1):129-40. PubMed ID: 21541658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laminaria japonica polysaccharide attenuates podocyte epithelial-mesenchymal transformation via TGF-β1-mediated Smad3 and p38MAPK pathways.
    Li XY; Chen HR; Kuang DD; Pan LH; Li QM; Luo JP; Zha XQ
    Int J Biol Macromol; 2023 Jun; 241():124637. PubMed ID: 37121417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte injury and overexpression of vascular endothelial growth factor and transforming growth factor-beta 1 in adriamycin-induced nephropathy in rats.
    Yang W; Wang J; Shi L; Yu L; Qian Y; Liu Y; Wang W; Cheng S
    Cytokine; 2012 Aug; 59(2):370-6. PubMed ID: 22579701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Protease-Activated Receptor 2 in Regulating Focal Segmental Glomerulosclerosis.
    Wang Y; He Y; Wang M; Lv P; Liu J; Wang J
    Cell Physiol Biochem; 2017; 41(3):1147-1155. PubMed ID: 28245472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
    Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis.
    Finer G; Schnaper HW; Kanwar YS; Liang X; Lin HY; Hayashida T
    Kidney Int; 2012 Sep; 82(5):525-36. PubMed ID: 22534961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
    Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
    Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAD2B-mediated cell cycle reentry of podocytes is involved in the pathogenesis of FSGS.
    Bao D; Su H; Lei CT; Tang H; Ye C; Xiong W; He FF; Lin JH; Hammes HP; Zhang C
    Int J Biol Sci; 2021; 17(15):4396-4408. PubMed ID: 34803506
    [No Abstract]   [Full Text] [Related]  

  • 15. Blocking ribosomal protein S6 phosphorylation inhibits podocyte hypertrophy and focal segmental glomerulosclerosis.
    Li F; Fang Y; Zhuang Q; Cheng M; Moronge D; Jue H; Meyuhas O; Ding X; Zhang Z; Chen JK; Wu H
    Kidney Int; 2022 Jul; 102(1):121-135. PubMed ID: 35483522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
    Marshall CB; Krofft RD; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Notch1-dependent effects on glomerular parietal epithelial cells promotes collapsing focal segmental glomerulosclerosis with progressive podocyte loss.
    Ueno T; Kobayashi N; Nakayama M; Takashima Y; Ohse T; Pastan I; Pippin JW; Shankland SJ; Uesugi N; Matsusaka T; Nagata M
    Kidney Int; 2013 Jun; 83(6):1065-75. PubMed ID: 23447065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of fibroblast specific protein 1 expression in the progression of adriamycin-induced glomerulosclerosis.
    Nakatani K; Asai O; Konishi N; Iwano M
    Biochem Biophys Res Commun; 2021 Aug; 567():148-153. PubMed ID: 34153685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced podocyte expression of alpha3beta1 integrins and podocyte depletion in patients with primary focal segmental glomerulosclerosis and chronic PAN-treated rats.
    Chen CA; Hwang JC; Guh JY; Chang JM; Lai YH; Chen HC
    J Lab Clin Med; 2006 Feb; 147(2):74-82. PubMed ID: 16459165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of TGF-beta on podocyte growth and disease progression in proliferative podocytopathies.
    Lee HS; Song CY
    Kidney Blood Press Res; 2010; 33(1):24-9. PubMed ID: 20185928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.